Creandum is a European venture capital firm that backs technology companies.
The Series A round was co-led by General Catalyst and Voyager Ventures to support software development and market expansion.
"We’re delighted with the fundraise, and to be continuing our close work with General Catalyst. I’m also very excited to be welcoming Voyager on board, bringing their deep climate expertise to the world of logistics."
The round was led by Creandum to support international growth and product scaling.
"We spent eleven years at JP Morgan,"
The funding round was led by Shift4Good to support the company's growth and recent acquisition of Cylantro.
"We’re excited to welcome onboard the Cylantro team to Laka. Thomas and his team have built up a fantastic offering in France, and we can’t wait to ramp up our presence across the country. E-bikes are expected to outgrow car sales by 2025 in Europe and we see huge potential in France, where the sales of bikes and e-bikes are growing at double-digits. We are also excited to welcome Shift4Good as an investor, and we look forward to working with them to expand our commitments to decarbonising mobility, by making it easier for consumers to insure and protect their bikes or e-bikes."
The Series A round was led by Creandum with backing from Paladin Capital Group and Plural.
"Our vision is for ethical, empathetic AI to enhance how visual content is experienced online. We’ve always focused on how we might be able to use AI to ensure a safer online experience, and keep up with the pace of internet content. This funding enables us to stay at the forefront of video understanding research and fulfil our mission of making the internet better,"
Creandum led the Series A round with participation from Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective.
"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."
